LogoCrystal's MCW Coder Hub

K12.30

3 min read

Here is a detailed guide note for K12.30, formatted as clean text for your reference.

K12.30: Oral mucositis (ulcerative), unspecified

Description

  • Definition: Inflammation and ulceration of the oral mucosa (lining of the mouth) and/or oropharynx where the underlying cause is not documented.
  • Includes: Mucositis (oral) (oropharyngeal).
  • Clinical Context: This code represents a breakdown of the epithelial lining of the mouth, often manifesting as painful ulcers, erythema, and difficulty swallowing.

Body area

Includes / Excludes

Risk Adjustment (HCC) Status

  • HCC Weight: No.
  • Clinical Note: This code generally does not map to a Hierarchical Condition Category (HCC). It is considered an acute manifestation.
  • Important: If the mucositis is a complication of cancer treatment (chemotherapy/radiation), the cancer diagnosis itself will carry the HCC weight, but the mucositis code provides medical necessity for supportive care (e.g., hydration, pain management).

Coding Guidelines & Specificity Alerts

  • “Unspecified” Risk: This code should be avoided if the cause is known. Payer policies often deny unspecified codes when a more specific cause is clinically evident.
  • Better Specific Codes (If cause is known):
    • K12.31: Oral mucositis (ulcerative) due to antineoplastic therapy (Chemotherapy).
      • Requirement: You must also code the adverse effect of the drug (e.g., T45.1X5).
    • K12.32: Oral mucositis (ulcerative) due to other drugs.
      • Requirement: You must also code the adverse effect of the specific drug (e.g., T36-T50).
    • K12.33: Oral mucositis (ulcerative) due to radiation.
      • Requirement: You should use an external cause code (e.g., W88-W90) to identify the radiation source.
    • K12.39: Other oral mucositis (ulcerative) - e.g., Viral oral mucositis.

Excludes2 Notes (Can be billed together if distinct)

  • Gastrointestinal mucositis (ulcerative) (K92.81).
  • Mucositis (ulcerative) of vagina and vulva (N76.81).
  • Nasal mucositis (ulcerative) ([[J34.81]]).

Common Associated CPT Codes

  • Evaluation & Management (E/M):
    • 99202-99215: Office or other outpatient visits.
      • Note: The level of service is often driven by the risk of morbidity (e.g., difficulty eating/drinking leading to dehydration) and Prescription Drug Management (e.g., prescribing “Magic Mouthwash” or antifungals).
  • Procedures:

Documentation Checklist

  • Etiology: Is the mucositis caused by chemotherapy, radiation, or a specific medication? If so, document it to use the K12.31-K12.33 range.
  • Site: Does it involve the mouth, pharynx, or esophagus?
  • Symptoms: Document pain, bleeding, or inability to eat/drink to support the medical decision-making (MDM) level for E/M services.

Common modifiers (CPT)

ModifierMeaning (high-level)Typical use cases
-25Significant, separately identifiable E/ME/M plus same-day procedure/testing
-59Distinct procedural serviceTo indicate a distinct service when appropriate (NCCI considerations)
-24Unrelated E/M during postop periodWhen rules for global periods apply

Common CPTs used with this diagnosis (examples)

  • Office/outpatient E/M as appropriate to documentation and patient status (e.g., 99213 for established patient).​

  • If mucositis is due to cancer therapy, payers may also require adverse-effect and external-cause coding (e.g., K12.31 plus T45.1X5 and/or Y84.2 when applicable).​

Example coding

Example: Provider documents “ulcerative oral mucositis” without documenting etiology (no radiation/drug/chemo attribution stated) → K12.30.[

Graph View

Recent Notes